Amgen Inc. (NASDAQ:AMGN) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. Amgen Inc. (NASDAQ:AMGN) has ...

Bristol Myers Squibb BMY and Amgen AMGN are among the largest global biotechnology companies with broad and diverse ...

Amgen’s 17.6% return over the past six months has outpaced the S&P 500 by 6.3%, and its stock price has climbed to $328.43 ...

Amgen Inc. raises 2025 revenue guidance on strong Repatha and Imdelltra sales and dividend hike. Click for this AMGN update.

Amgen AMGN reported the latest data from the phase III MINT study that evaluated the rare disease drug Uplizna (inebilizumab) for label expansion in generalized myasthenia gravis (gMG) indication.

On December 12, Morgan Stanley cut its price target for Amgen Inc. (NASDAQ:AMGN) from $329 to $304, but kept its Equal Weight rating.

In terms of shares owned, we count 1 of the above funds having increased existing AMGN positions from 03/31/2025 to 06/30/2025, with 7 having decreased their positions. Looking beyond these particular ...

In the latest close session, Amgen (AMGN) was up +1.22% at $331.39. The stock exceeded the S&P 500, which registered a gain ...

Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen today and set a price target of $381.00. Claim 50% Off TipRanks Premium and Invest with Confidence. Unlock he ...